Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.

Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MCJ, van Genderen PJJ, Goorhuis A, Grobusch MP, Lashof AMO, Molhoek N, Schultsz C, Stobberingh EE, Verbrugh HA, de Jong MD, Melles DC, Penders J.

Lancet Infect Dis. 2017 Jan;17(1):78-85. doi: 10.1016/S1473-3099(16)30319-X. Epub 2016 Oct 14.

PMID:
27751772
2.

The Carriage Of Multiresistant Bacteria After Travel (COMBAT) prospective cohort study: methodology and design.

Arcilla MS, van Hattem JM, Bootsma MC, van Genderen PJ, Goorhuis A, Schultsz C, Stobberingh EE, Verbrugh HA, de Jong MD, Melles DC, Penders J.

BMC Public Health. 2014 Apr 28;14:410. doi: 10.1186/1471-2458-14-410.

3.

Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.

Reuland EA, Sonder GJ, Stolte I, Al Naiemi N, Koek A, Linde GB, van de Laar TJ, Vandenbroucke-Grauls CM, van Dam AP.

Clin Microbiol Infect. 2016 Aug;22(8):731.e1-7. doi: 10.1016/j.cmi.2016.05.003. Epub 2016 May 17.

4.

Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study.

ÖstholmBalkhed Å, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, Hällgren A; Southeast Sweden Travel Study Group.

PLoS One. 2018 Oct 24;13(10):e0205504. doi: 10.1371/journal.pone.0205504. eCollection 2018.

5.

Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers.

Mizuno Y, Miura Y, Yamaguchi T, Matsumoto T.

Travel Med Infect Dis. 2016 Nov - Dec;14(6):561-567. doi: 10.1016/j.tmaid.2016.09.012. Epub 2016 Oct 18.

PMID:
27769900
6.

Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.

Ostholm-Balkhed A, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, Hällgren A; Travel Study Group of Southeast Sweden.

J Antimicrob Chemother. 2013 Sep;68(9):2144-53. doi: 10.1093/jac/dkt167. Epub 2013 May 14.

7.

Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.

Lübbert C, Straube L, Stein C, Makarewicz O, Schubert S, Mössner J, Pletz MW, Rodloff AC.

Int J Med Microbiol. 2015 Jan;305(1):148-56. doi: 10.1016/j.ijmm.2014.12.001. Epub 2014 Dec 9.

PMID:
25547265
8.

High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.

Kuenzli E, Jaeger VK, Frei R, Neumayr A, DeCrom S, Haller S, Blum J, Widmer AF, Furrer H, Battegay M, Endimiani A, Hatz C.

BMC Infect Dis. 2014 Oct 1;14:528. doi: 10.1186/1471-2334-14-528.

9.

High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia.

Barreto Miranda I, Ignatius R, Pfüller R, Friedrich-Jänicke B, Steiner F, Paland M, Dieckmann S, Schaufler K, Wieler LH, Guenther S, Mockenhaupt FP.

J Travel Med. 2016 Feb 8;23(2):tav024. doi: 10.1093/jtm/tav024. Print 2016 Feb.

PMID:
26858272
10.

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission.

Maataoui N, Mayet A, Duron S, Delacour H, Mentré F, Laouenan C, Desvillechabrol D, Cokelaer T, Meynard JB, Ducher A, Andremont A, Armand-Lefèvre L, Mérens A.

Clin Microbiol Infect. 2019 May;25(5):631.e1-631.e9. doi: 10.1016/j.cmi.2018.07.030. Epub 2018 Aug 9.

PMID:
30099136
11.

Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.

Titelman E, Hasan CM, Iversen A, Nauclér P, Kais M, Kalin M, Giske CG.

Clin Microbiol Infect. 2014 Aug;20(8):O508-15. doi: 10.1111/1469-0691.12559. Epub 2014 Feb 18.

12.

Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.

Kantele A, Lääveri T, Mero S, Vilkman K, Pakkanen SH, Ollgren J, Antikainen J, Kirveskari J.

Clin Infect Dis. 2015 Mar 15;60(6):837-46. doi: 10.1093/cid/ciu957. Epub 2015 Jan 21.

13.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.

Lääveri T, Vlot JA, van Dam AP, Häkkinen HK, Sonder GJB, Visser LG, Kantele A.

BMC Infect Dis. 2018 Jul 23;18(1):341. doi: 10.1186/s12879-018-3245-z.

14.

International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.

Strysko JP, Mony V, Cleveland J, Siddiqui H, Homel P, Gagliardo C.

Travel Med Infect Dis. 2016 Nov - Dec;14(6):568-571. doi: 10.1016/j.tmaid.2016.11.012. Epub 2016 Nov 24.

PMID:
27890813
15.

Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study.

Angelin M, Forsell J, Granlund M, Evengård B, Palmgren H, Johansson A.

Travel Med Infect Dis. 2015 May-Jun;13(3):223-9. doi: 10.1016/j.tmaid.2015.04.007. Epub 2015 May 5.

PMID:
25982453
16.

Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands.

Paltansing S, Vlot JA, Kraakman ME, Mesman R, Bruijning ML, Bernards AT, Visser LG, Veldkamp KE.

Emerg Infect Dis. 2013 Aug;19(8):1206-13. doi: 10.3201/eid.1908.130257.

17.

Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.

Kim J, Lee JY, Kim SI, Song W, Kim JS, Jung S, Yu JK, Park KG, Park YJ.

Ann Lab Med. 2014 Jan;34(1):20-5. doi: 10.3343/alm.2014.34.1.20. Epub 2013 Dec 6.

18.

Varying high levels of faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health.

Sun Q, Tärnberg M, Zhao L, Stålsby Lundborg C, Song Y, Grape M, Nilsson M, Tomson G, Nilsson LE.

PLoS One. 2014 Nov 18;9(11):e113121. doi: 10.1371/journal.pone.0113121. eCollection 2014.

19.

Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children.

Islam S, Selvarangan R, Kanwar N, McHenry R, Chappell JD, Halasa N, Wikswo ME, Payne DC, Azimi PH, McDonald LC, Gomez-Duarte OG.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):234-240. doi: 10.1093/jpids/pix045.

20.

Epidemiology and risk factors for faecal extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from residents of seven nursing homes in western Shanghai, China.

Zhao SY, Zhang J, Zhang YL, Wang YC, Xiao SZ, Gu FF, Guo XK, Ni YX, Han LZ.

Epidemiol Infect. 2016 Mar;144(4):695-702. doi: 10.1017/S0950268815001879. Epub 2015 Aug 11.

PMID:
26260355

Supplemental Content

Support Center